 |
Daunorubicin citrate liposome injection |
|---|---|
| Trade Name | Daunoxome |
| Orphan Indication | Patients with advanced HIV-associated Kaposi's sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 1993-05-14 00:00:00 |
| Sponsor | NeXstar Pharmaceuticals, Inc.;650 Cliffside Drive;San Dimas, California, 91773 |
